Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MTNBthis companyMatinas BioPharma Holdings, Inc.	$1.18	-0.29×	0.66×	0×	-0.06×	415.1%	0.0%	0.0%	0.0%	-214.2%	-108.1%	-218.6%	0.28×	0.27×	0×	2.79×	0.0%	1	-94.31	3	B-
ACXPAcurx Pharmaceuticals, Inc.	$1.08	-0.47×	0.71×	0×	0.48×	374.0%	0.0%	0.0%	0.0%	-151.2%	-153.6%	-181.9%	0×	0.95×	0×	3.18×	0.0%	2	-10.22	2	B-
CDIOCardio Diagnostics Holdings, Inc.	$1.80	-0.73×	0.68×	320.16×	-0.05×	34.3%	100.0%	-43737.5%	-43832.5%	-93.2%	-84.5%	-124.6%	0.1×	0.73×	-438.08×	9.79×	0.0%	1	-1.62	3	B
HCWBHCW Biologics Inc.	$1.01	-0.09×	0.74×	37.52×	-1.22×	-4178.9%	20.0%	-20757.6%	-14677.1%	-287.9%	-109.7%	-658.1%	2.46×	-0.86×	-9×	0.11×	0.0%	2	-6.89	2	C
IBOImpact BioMedical Inc.	$4.03	-1.33×	1.26×	497.66×	-1.27×	-100.4%	-1225.0%	-13343.8%	-36993.8%	-93.9%	-21.6%	-11.9%	0×	0×	-5.38×	0.35×	0.0%	4	2.31	2	C+
KTTAPasithea Therapeutics Corp.	$0.57	-0.44×	0.16×	0×	2.28×	2031.8%	0.0%	0.0%	0.0%	-37.0%	-37.7%	-167.7%	0×	2.73×	0×	11.35×	0.0%	2	1.38	2	B-
Peer median	—	-0.47×	0.71×	37.52×	-0.05×	34.3%	0.0%	-13343.8%	-14677.1%	-93.9%	-84.5%	-167.7%	0×	0.73×	-5.38×	3.18×	0.0%	2	-1.62	2	—